Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2000
03/15/2000EP0985044A1 Anti-cancer vaccine
03/15/2000EP0985040A1 Preparation of glycosylated tumor necrosis factor
03/15/2000EP0985038A1 Sodium channel receptor
03/15/2000EP0985037A1 Human multiple endocrine neoplasia type 1 protein
03/15/2000EP0985035A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
03/15/2000EP0984982A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
03/15/2000EP0984963A1 Novel compounds
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS
03/15/2000EP0984954A1 Anti-mitotic agents which inhibit tubulin polymerization
03/15/2000EP0984940A1 Cyanoamidines as cell proliferation inhibitors
03/15/2000EP0984939A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984938A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984937A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984936A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/15/2000EP0984791A1 Ternary ligand complexes useful as radiopharmaceuticals
03/15/2000EP0984784A2 Anti-cancer products for treating cystic fibrosis
03/15/2000EP0984779A1 Somatostatin agonists
03/15/2000EP0984692A1 Novel angiogenesis inhibitors
03/15/2000EP0667351B1 Compound uch9
03/15/2000EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/15/2000EP0610286B1 Recombinant immunotoxins
03/15/2000EP0550580B1 Uracil reductase inactivator
03/15/2000EP0549702B1 Use of recombinant colony stimulating factor-1
03/15/2000CN1247531A Arylsulfonyl hydroxamic acid derivatives
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1247228A Human pluripotent leukosis cell differentiated correlative gene
03/15/2000CN1050365C Method for prepn. of hexan-2-olefin pyranoseoside of alcohol and phenol
03/14/2000USRE36617 (Substituted aralkyl) heterocyclic compounds
03/14/2000US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037467 Methods for preparing carbohydrate-containing hydrophilic polymers
03/14/2000US6037376 Methods for therapy of cancer
03/14/2000US6037350 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6036955 Antitumor agents
03/14/2000US6036954 Polypeptides with sequence
03/14/2000CA2195213C Use of droloxifene for the treatment of cardiovascular diseases
03/14/2000CA2184919C New piperazine derivatives and methods for the preparation thereof and compositions containing the same
03/14/2000CA2132424C Antisense oligonucleotide inhibition of papillomavirus
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/14/2000CA2071205C Cell surface antigen associated with cellular apoptosis
03/14/2000CA2006969C Polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide
03/09/2000WO2000012758A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012739A1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors
03/09/2000WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012726A2 Rationally designed heparinases derived from heparinase i and ii
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012556A1 High-affinity antibodies
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012542A2 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
03/09/2000WO2000012541A2 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012519A1 Phosphoepoxides, method for making same and uses
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
03/09/2000WO2000012508A2 Pyrrolbenzodiazepines
03/09/2000WO2000012507A2 Pyrrolobenzodiazepines
03/09/2000WO2000012506A2 Collections of compounds
03/09/2000WO2000012499A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012496A1 Novel cdk inhibitors having flavone structure
03/09/2000WO2000012486A1 Pyrimidine compounds
03/09/2000WO2000012485A1 Pyrimidine compounds
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012127A2 Dna cancer vaccine and methods for its use
03/09/2000WO2000012122A2 Low-molecular fragments of hyaluronic acid for the preparation of vaccines
03/09/2000WO2000012120A1 A pharmaceutical composition containing calcineurin b subunit
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012089A1 Novel angiogenesis inhibitors
03/09/2000WO2000012086A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012083A1 Formamides as therapeutic agents
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012066A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000WO1999065515A3 Combination of radiotherapy and anti-angiogenic factors
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999060013A3 Il-6 antagonist peptides
03/09/2000WO1999053949A3 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
03/09/2000DE19940407A1 Stable, potent, non-toxic, broad-spectrum antitumor agent comprising dixanthate-platinum complex, especially effective against small cell lung cancer and colorectal carcinoma
1 ... 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 ... 2211